Table of Contents
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: INTRODUCTION
• Market outline
PART 05: MARKET LANDSCAPE
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: MARKET SEGMENTATION BY END-USER
• Overview
• Comparison by end-user
• Pharmaceutical and biotechnology companies
• Medical device companies
• CRO
• Market opportunity by end-user
PART 07: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas
• EMEA
• APAC
• Market opportunity
PART 08: DECISION FRAMEWORK
PART 09: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 10: MARKET TRENDS
• Increasing outsourcing of analytical testing services
• Growing focus on promotional activities
• Increasing M&A
PART 11: VENDOR LANDSCAPE
• Competitive scenario
PART 12: VENDOR ANALYSIS
• Vendor overview
• Charles River Laboratories
• Eurofins Scientific
• SGS
• Thermo Fisher Scientific
• Other prominent vendors
PART 13: APPENDIX
• List of abbreviations
Exhibit 01: Global healthcare analytical testing services market 2016-2021 ($ millions)
Exhibit 02: Five forces analysis
Exhibit 03: End-user: Market share and forecast 2016-2021
Exhibit 04: Comparison by end-user
Exhibit 05: Pharmaceutical and biotechnology companies: Market size and forecast 2016-2021 ($ millions)
Exhibit 06: Pharmaceutical and biotechnology companies: Year-over-year growth 2017-2021
Exhibit 07: Depiction of services offered across various phases of drug development cycle
Exhibit 08: Medical device companies: Market size and forecast 2016-2021 ($ millions)
Exhibit 09: Common mandates in medical device manufacturing
Exhibit 10: Medical device companies: Year-over-year growth 2017-2021
Exhibit 11: CRO: Market size and forecast 2016-2021 ($ millions)
Exhibit 12: CRO: Year-over-year growth 2017-2021
Exhibit 13: Global healthcare analytical testing services market by geography: Market size and forecast
Exhibit 14: Regional comparison
Exhibit 15: Americas: Market size and forecast 2016-2021 ($ millions)
Exhibit 16: Personalized medicines across different disease areas
Exhibit 17: Americas: Year-over-year growth 2017-2021
Exhibit 18: Top three countries in Americas
Exhibit 19: EMEA: Market size and forecast 2016-2021 ($ millions)
Exhibit 20: EMEA: Year-over-year growth 2017-2021
Exhibit 21: Top three countries in EMEA
Exhibit 22: APAC: Market size and forecast 2016-2021 ($ millions)
Exhibit 23: APAC: Year-over-year growth 2017-2021
Exhibit 24: Top three countries in APAC
Exhibit 25: Factors responsible for growth of biotechnology and pharmaceuticals market
Exhibit 26: Advantages of QbD approach over traditional approach
Exhibit 27: Key challenges involved in services marketing
Exhibit 28: Types of outsourcing techniques prevalent in healthcare industry
Exhibit 29: Digital reach of the key vendors
Exhibit 30: Recent acquisitions by two key vendors
Exhibit 31: Strategic success factors for vendors
Exhibit 32: Charles River Laboratories: Company profile
Exhibit 33: Charles River Laboratories: Strength analysis
Exhibit 34: Charles River Laboratories: Strategy assessment
Exhibit 35: Charles River Laboratories: Opportunity assessment
Exhibit 36: Eurofins Scientific: Company profile
Exhibit 37: Eurofins Scientific: Strength analysis
Exhibit 38: Eurofins Scientific: Strategy assessment
Exhibit 39: Eurofins Scientific: Opportunity assessment
Exhibit 40: SGS: Company profile
Exhibit 41: SGS: Strength analysis
Exhibit 42: SGS: Strategy assessment
Exhibit 43: SGS: Opportunity assessment
Exhibit 44: Thermo Fisher Scientific: Company profile
Exhibit 45: Thermo Fisher Scientific: Strength analysis
Exhibit 46: Thermo Fisher Scientific: Strategy assessment
Exhibit 47: Thermo Fisher Scientific: Opportunity assessment
【掲載企業】
Charles River Laboratories, Eurofins Scientific, SGS, Thermo Fisher Scientific, Anacura, Bioreliance Corporation, Envigo, Exova, Intertek Group, Medistri, Pace Analytical Services, Pharmaceutical Product Development, Source Bioscience, and WuXi AppTec.
【レポートのキーワード】
ヘルスケア分析試験サービス
【免責事項】
http://www.globalresearch.jp/disclaimer